Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05683366 · ClinicalTrials.gov registry record
Philps FAST2022 picoSAT Pulse Oximetry Desaturation Study
A clinical trial, sponsored by Philips Clinical & Medical Affairs Global.
- Completed
- Registry status
- 72
- Enrollment target
NCT05683366: Completed study, sponsored by Philips Clinical & Medical Affairs Global.
NCT05683366 is a clinical trial that has completed, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 72 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05683366 has completed, sponsored by Philips Clinical & Medical Affairs Global.
- COMPLETED
- Registry status
- 72 participants
- Enrollment target
Study Summary
Validation study to compare the accuracy of non-invasive Philips SpO2 sensors in detecting blood oxygen levels compared to invasive methods requiring a blood draw and lab analysis.
Interventions
- DEVICE No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2022-12-13 |
| Est. Completion | 2023-09-07 |
What the finished NCT05683366 record still lists
NCT05683366 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 72 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT05683366 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05683366 about?
NCT05683366 is a clinical study titled "Philps FAST2022 picoSAT Pulse Oximetry Desaturation Study". Validation study to compare the accuracy of non-invasive Philips SpO2 sensors in detecting blood oxygen levels compared to invasive methods requiring a blood draw and lab analysis.
What is the current status of trial NCT05683366?
This trial is currently completed. The enrollment target is 72 participants. The study started on 2022-12-13. Estimated completion is 2023-09-07.
What interventions are being tested in trial NCT05683366?
The interventions under investigation include: No Intervention (DEVICE).
Who is sponsoring clinical trial NCT05683366?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI